SCHEMBL13634725

SCHEMBL13634725

CCCNC(=O)c1cc(CN2CCO[C@@H](CC)C2)ccc1NC(=O)c1csc(N2CC[C@H](OC)C2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 4/20 0.46
SIGMAR1 Q99720 2/20 0.36
MEN1 O00255 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
KMT2A Q03164 2/20 0.36
GRM2 Q14416 2/20 0.36
LMNA P02545 1/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADRA2B P18089 1/20 0.36
HTR2C P28335 1/20 0.36
SLC6A4 P31645 1/20 0.36
DRD3 P35462 1/20 0.36
HTR2B P41595 1/20 0.36
KCNH2 Q12809 1/20 0.36
SCD O00767 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13634657 0.93 DRD4 (0.41) DRD4MEN1CYP1A2CYP3A4CYP2C9
SCHEMBL13634656 0.93 DRD4 (0.41) DRD4MEN1CYP1A2CYP3A4CYP2C9
SCHEMBL13634884 0.91 S1PR1 (0.40) DRD4MEN1CYP1A2CYP3A4CYP2C9
SCHEMBL13638830 0.90 DRD4 (0.42) DRD4SIGMAR1MEN1CYP1A2CYP3A4
SCHEMBL13634530 0.89 DRD4 (0.45) DRD4SIGMAR1MEN1CYP1A2CYP3A4
SCHEMBL13634817 0.89 DRD4 (0.45) DRD4SIGMAR1MEN1CYP1A2CYP3A4
SCHEMBL13634563 0.88 PDCD1 (0.37) DRD4GRM2LMNASCDSCD5
SCHEMBL13634887 0.88 GLS (0.36) DRD4LMNASCDSCD5PARP1
SCHEMBL13634886 0.88 ACKR3 (0.38) DRD4GRM2SCDSCD5PARP1
SCHEMBL13639001 0.87 KMT2A (0.38) DRD4MEN1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304547-B2 Azolecarboxamide compound or salt thereof ASTELLAS PHARMA INC. (JP) 2012-11-06 US disclosed